Hearing on release of Watts autopsies set for December

-
Watts

Watts

The hearing on a petition to seal the autopsy reports in the murder case against Christopher Watts will be Dec. 21 in Weld County District Court.

The Weld County coroner on Oct. 15 filed a petition to seal the autopsies of 34-year-old Shanann Watts, and her two children, 4-year-old Bella and 3-year-old Celeste. Christoper Watts, 33, is accused of killing his wife, who was 15 weeks pregnant, and two daughters. He is charged with five counts of first-degree murder, one count of first-degree unlawful termination of pregnancy and three counts of tampering with a deceased human body.

Weld County District Court Judge Todd Taylor last week filed an order calling on the coroner to file for a hearing by this Friday.

Around 35 parties have filed Colorado Open Records Act requests for the autopsies. A number of those requests are from media organizations, including the Longmont Times-Call, which are being represented by Steven Zansberg of Ballard, Spahr, LLP in Denver.

The coroner filed the petition to seal the reports citing arguments made previously by Weld County District Attorney Michael Rourke. Rourke argued the reports could taint potential jurors or witnesses who have not yet been interviewed.

Advertisement

Both the district attorney and Watts' public defenders have been granted the right to intervene in the hearing on Dec. 21.

Watts' attorneys have not opposed releasing the autopsy reports.

Madeline St. Amour: 303-684-5212, mstamour@prairiemountainmedia.com



https://ift.tt/2SvlKEl

Comments

Post a Comment

Popular posts from this blog

Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

-
Image
Medicare Open Enrollment ends December 7. The easy choice is to stay with all-in-one Medicare Advantage instead of switching to Traditional Medicare plus a supplement and drug plan. The hard one is whether to switch between Medicare Advantage plans, from a well-liked one to one accepted at a so-called top-10 hospital. Humana Gold Plus, a Medicare Advantage HMO, has served me well for five years. Hearing aids cost me only $10 after its $2,000 allowance. Routine doctor and dentist appointments and my medication cost nothing. But Humana Gold Plus is not accepted by Northwestern Memorial Hospital, the nearby hospital that US News & World Report ranks as the tenth best in the country, or by Northwestern Medicine physicians. My primary care physician is in an Advocate Medical Group. If I were hospitalized, it would be at Advocate Illinois Masonic Medical Center. If I had a serious illness, I’d see specialists in Advocate’s network. Illinois Masonic is not a second-rate hospital, and
Read more

Minnesota veterans blame 3M's 'defective' ear plugs for hearing damage - KSTP

-
Image
3M did not admit any wrongdoing as part of that settlement. Read 3M's full statement on the ear plugs here. "We deny this product was defectively designed," a company spokesperson said in a statement to 5 INVESTIGATES, adding they will "defend against the allegations in these lawsuits." More than 630 lawsuits have been filed and will be heard in a federal court in Florida. An attorney involved with the multi-district litigation says roughly 30 have been filed by veterans who live in Minnesota. Constant ringing Sarah Kay Carlson, an Army veteran from St. Paul, filed her lawsuit in April, claiming 3M exposed her and thousands of other Marines and soldiers to "extremely dangerous and disabling noise." 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (PDF) 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (Text) Carlson, who was deployed as part of Operation Iraqi Freedom in the late 2000s, provided security to convoys t
Read more

Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics

-
Image
hemophilia c factor 11 :: Article Creator Regeneron Reports Fourth Quarter And Full Year 2023 Financial And Operating Results Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM(a)(b), revenuesincreased 14% Full year 2023 revenues increased 8% to $13.12 billion versus full year 2022;excluding Ronapreve(a), revenuesincreased 12% Fourth quarter 2023 Dupixent®global net sales(recorded by Sanofi) increased 31% to $3.22 billion versus fourth quarter 2022; full year 2023 Dupixent global net sales increased 33% to $11.59 billion versus 2022 Fourth quarter 2023 U.S. Net sales for EYLEA®HD and EYLEA®were $1.46 billion, including $123 million from EYLEA HD; full year 2023 U.S. Net sales for EYLEA HD and EYLEA were $5.89 billion, including $166 million from EYLEA HD following its August 2023 FDA approval Fourth quarter 2023 Libtayo®global n
Read more